Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 89 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC USA |
 |
09/05/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
Durham, NC USA |
 |
06/16/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
Charlotte, NC USA |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
 |
Winston-Salem, NC USA |
 |
04/21/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Durham, NC USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
 |
Durham, NC USA |
 |
11/08/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Durham, NC USA |
 |
10/27/2008 |
 |
 |
 |
Details |
 |
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan |
 |
Durham, NC USA |
 |
10/09/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
04/27/2008 |
 |
 |
 |
Details |
 |
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
 |
Durham, NC USA |
 |
04/15/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
Durham, NC USA |
 |
04/15/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Goldsboro, NC USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
 |
Durham, NC USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe] |
 |
Durham, NC USA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Winston-Salem, NC USA |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
 |
Durham, NC USA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
 |
Durham, NC USA |
 |
08/20/2007 |
 |
 |
 |
Details |
 |
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
08/19/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Charlotte, NC USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
 |
Chapel Hill, NC USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of Bevacizumab (Avastin) in Combination With Metronomic Temozolomide (Temodar)for Recurrent Malignant Glioma |
 |
Durham, NC USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
 |
Winston-Salem, NC USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II treatments with Temodar® for adults with progressive,resistant or recurrent meningioma. |
 |
Durham, NC USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
 |
Durham, NC USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |